Dosage form: nasal spray
Drug class:Antimigraine agents
Medically reviewed by Drugs.com. Last updated on Nov 1, 2021.
On This Page
- Indications and Usage
- Dosage and Administration
- Dosage Forms and Strengths
- Contraindications
- Warnings and Precautions
- Adverse Reactions/Side Effects
- Drug Interactions
- Use In Specific Populations
- Overdosage
- Description
- Clinical Pharmacology
- Nonclinical Toxicology
- Clinical Studies
- How Supplied/Storage and Handling
- Patient Counseling Information
Indications and Usage for Zolmitriptan Nasal Spray
Zolmitriptan Nasal Spray is indicated for the acute treatment of migraine with or without aura in adults and pediatric patients 12 years of age and older.
Limitations of Use:
- •
- Only use zolmitriptan if a clear diagnosis of migraine has been established. If a patient has no response to zolmitriptan treatment for the first migraine attack, reconsider the diagnosis of migraine before zolmitriptan is administered to treat any subsequent attacks.
- •
- Zolmitriptan is not indicated for the prevention of migraine attacks.
- •
- Safety and effectiveness of zolmitriptan have not been established for cluster headache.
- •
- Not recommended in patients with moderate or severe hepatic impairment [see Dosage and Administration (
MEDICAL DEPARTMENTS
CardiologyPediatricsDiabetes CarePre-natal CareUltrasound Echocardiogram